Impact of SER 109, an Investigational Microbiome Therapeutic on Health-Related Quality of Life in Patients With Recurrent Clostridioides Difficile Infection: Results From ECOSPOR III, a Placebo-Controlled Clinical Trial

被引：0
|
作者：
Brown, Lisa [1 ]
Elizabeth, Hohmann [1 ]
Paul, Feuerstadt [1 ]
Caterina, Oneto [1 ]
Berenson, Charles [1 ]
Christine, Lee [1 ]
Sissi, Pham [1 ]
Ray, Reese Pat [1 ]
Henry, Wu [1 ]
Elaine, Wang [1 ]
Lisa, von Moltke [1 ]
Kevin, Garey [1 ]
机构：
[1] Seres Therapeut, Brooklyn, NY USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2021年 / 46卷 / SUPPL 1期
关键词：
Microbiome; Microbiota-Gut-Brain Axis; Microbiota; Gut-Brain Axis; Fecal Microbiota Transplant;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P334
引用
收藏
页码：253 / 253
页数：1
相关论文
共 50 条
  • [41] Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660-A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection
    Dubberke, Erik R.
    Lee, Christine H.
    Orenstein, Robert
    Khanna, Sahil
    Hecht, Gail
    Gerding, Dale N.
    CLINICAL INFECTIOUS DISEASES, 2018, 67 (08) : 1198 - 1204
  • [42] INTRAVENOUSLY ADMINISTERED GOLIMUMAB SIGNIFICANTLY IMPROVES HEALTH RELATED QUALITY OF LIFE AND WORK PRODUCTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS OF A PHASE III, PLACEBO-CONTROLLED TRIAL
    Westhovens, R.
    Weinblatt, M. E.
    Han, C.
    Gathany, T.
    Kim, L.
    Mack, M.
    Lu, J.
    Baker, D.
    Mendelsohn, A.
    Bingham, C.
    VALUE IN HEALTH, 2012, 15 (04) : A42 - A42
  • [43] Impact of ustekinumab on health-related quality of life in Japanese patients with moderate-to-severe plaque psoriasis: Results from a randomized, double-blind, placebo-controlled phase 2/3 trial
    Nakagawa, Hidemi
    Schenkel, Brad
    Kato, Mai
    Kato, Takeshi
    Igarashi, Atsuyuki
    JOURNAL OF DERMATOLOGY, 2012, 39 (09): : 761 - 769
  • [44] Effect of ustekinumab on physical function and health-related quality of life in patients with psoriatic arthritis: a randomized, placebo-controlled, phase II trial
    Kavanaugh, Arthur
    Menter, Alan
    Mendelsohn, Alan
    Shen, Yaung-Kaung
    Lee, Seina
    Gottlieb, Alice B.
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (10) : 2385 - 2392
  • [45] ENGRAFTMENT OF SER-287, AN INVESTIGATIONAL MICROBIOME THERAPEUTIC, IS RELATED TO CLINICAL REMISSION IN A PLACEBO-CONTROLLED, DOUBLE-BLIND RANDOMIZED TRIAL (SERES-101) IN PATIENTS WITH ACTIVE MILD TO MODERATE ULCERATIVE COLITIS (UC)
    Simmons, Sheri
    Diao, Liyang
    O'Brien, Edward
    Chafee, Meghan
    Zhao, Jeff
    Bernardo, Patricia
    Cook, David
    Trucksis, Michele
    Henn, Matthew R.
    GASTROENTEROLOGY, 2018, 154 (06) : S1371 - S1372
  • [46] Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase III, placebo-controlled QUAZAR AML-001 trial
    Roboz, Gail J.
    Doehner, Hartmut
    Pocock, Christopher
    Dombret, Herve
    Ravandi, Farhad
    Jang, Jun Ho
    Selleslag, Dominik
    Mayer, Ji ri
    Martens, Uwe M.
    Liesveld, Jane
    Bernal, Teresa
    Wang, Ming Chung
    Yu, Peiwen
    Shi, Ling
    Guo, Shien
    La Torre, Ignazia
    Skikne, Barry
    Dong, Qian
    Braverman, Julia
    Nehme, Salem Abi
    Beach, C. L.
    Wei, Andrew H.
    HAEMATOLOGICA, 2021, 106 (12) : 3240 - 3244
  • [47] Week 24 Efficacy and Safety Data from PRISM3: A Randomized, Placebo-Controlled Trial Evaluating CP101, an Investigational Orally Administered Microbiome Therapeutic for the Prevention of Recurrent C. difficile Infection
    Allegretti, Jessica R.
    Kelly, Colleen R.
    Louie, Thomas
    Fisher, Monika
    Hota, Susy
    Misra, Bharat
    Van Hise, Nicholas W.
    Yen, Eugene F.
    Bullock, Jeff S.
    Pullman, John
    Nathan, Richard
    Silverman, Michael
    Davis, Ian
    McGill, Sarah
    Khanna, Sahil
    Pardi, Darrell
    Orenstein, Robert
    Grinspan, Ari
    El-Nachef, Najwa
    Kraft, Colleen S.
    Budree, Shrish
    Borody, Thomas J.
    Kassam, Zain
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S63 - S64
  • [48] Factors affecting the health-related quality of life of patients with cervical dystonia and impact of treatment with abobotulinumtoxinA (Dysport): results from a randomised, double-blind, placebo-controlled study
    Mordin, Margaret
    Masaquel, Catherine
    Abbott, Chandra
    Copley-Merriman, Catherine
    BMJ OPEN, 2014, 4 (10):
  • [49] Impact of imatinib rechallenge on health-related quality of life in patients with TKI-refractory gastrointestinal stromal tumours: Sub-analysis of the placebo-controlled, randomised phase III trial (RIGHT)
    Yoo, Changhoon
    Ryu, Min-Hee
    Nam, Byung-Ho
    Ryoo, Baek-Yeol
    Demetri, George D.
    Kang, Yoon-Koo
    EUROPEAN JOURNAL OF CANCER, 2016, 52 : 201 - 208
  • [50] The impact of incident vertebral and non-vertebral fragility fractures on health-related quality of life in established postmenopausal osteoporosis: Results from the teriparatide randomized, placebo-controlled trial in postmenopausal women
    Oglesby, AK
    Minshall, ME
    Shen, W
    Xie, S
    Silverman, SL
    JOURNAL OF RHEUMATOLOGY, 2003, 30 (07) : 1579 - 1583
12345